ReviewTropical medicine and health2025
Neglected tropical diseases elimination in Africa: lessons from regional control programmes.
Review in Tropical medicine and health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAfrica has made notable progress against Neglected Tropical Diseases (NTDs) using a whole-of-society approach that involved everyone, though sub-Saharan Africa still faces major challenges. Since the Expanded Special Project for the Elimination of Neglected Tropical Diseases (ESPEN) was launched in 2016, over 500 million people have been treated for NTDs like onchocerciasis, lymphatic filariasis, schistosomiasis, and soil-transmitted helminthiases. Nineteen African countries have eliminated at least one NTD, yet 44 out of 52 tracked nations still need preventive chemotherapy for multiple diseases. In 2022, 81 million people received schistosomiasis treatment, but adult coverage remains low due to limited praziquantel access. This paper documents lessons and success stories from regional initiatives such as the African Programme for Onchocerciasis Control (APOC), the Onchocerciasis Control Programme in West Africa (OCP), and the Guinea Worm Eradication Programme, including success stories from specific countries in implementing NTDs programmes and other health programmes (vaccine-preventable disease programmes, malaria, and some zoonotic disease programmes) for ESPEN and similar partnerships to guide future improvements in NTD elimination efforts.
methodsProgramme reports from the WHO African region on NTDs, and peer-reviewed journals and other published documents were assessed, supplemented by authors' wide experiences to gain insights into NTDs and communicable disease programme implementation across Africa. The manuscript was structured along the WHO health systems building blocks. Success stories were highlighted, lessons learned documented, and recommendations made. Contents were reviewed several times and independently by a small group. The authors' approval was secured before journal submission. FINDINGS AND
conclusionsLessons learned, and recommendations made are beneficial to partners and countries in achieving the 2030 NTDs elimination targets in the African region and beyond. They provide pathways to expanding the structure, direction, and scope of programme implementation for greater impact.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.